Results 31 to 40 of about 26,727 (247)

Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy [PDF]

open access: yes, 2019
Anti-phospholipase A2 receptor antibody; Membranous nephropathy; Spontaneous remissionAnticòs del receptor anti-fosfolipasa A2; Nefropatia membranosa; Remissió espontàniaAnticuerpo del receptor anti-fosfolipasa A2; Nefropatía membranosa; Remisión ...
Agraz Pamplona, Irene   +2 more
core   +3 more sources

Membranous nephropathy [PDF]

open access: yesBrazilian Journal of Nephrology, 2023
Membranous nephropathy is a glomerulopathy, which main affected target is the podocyte, and has consequences on the glomerular basement membrane. It is more common in adults, especially over 50 years of age.
Márcio Dantas   +5 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis

open access: yesFrontiers in Medicine, 2018
BackgroundM-type phospholipase A2 receptor (PLA2R) is known as a major antigen on podocytes, which is involved with the pathogenesis of idiopathic membranous nephropathy (iMN).
Weiying Li, Yuliang Zhao, Ping Fu
doaj   +1 more source

Critical evaluation of cancer risks in glomerular disease

open access: yesTranslational Oncology, 2022
The increased cancer incidence in patients with glomerular disease can be secondary to an intrinsic immune dysfunction associated with the disease or/and extrinsic factors, especially immunosuppressants. The treatment for paraneoplastic glomerulopathy is
Zaw Thet   +5 more
doaj   +1 more source

Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer

open access: yesFrontiers in Pharmacology, 2022
Background: This study aimed to evaluate clinical features and prognosis and therapy option of patients with different risk ranks based on antibody against the M-type phospholipase-A2-receptor (PLA2Rab) level in seropositive M-type phospholipase-A2 ...
Le Deng   +7 more
doaj   +1 more source

sj-pdf-1-cjk-10.1177_20543581211052729 – Supplemental material for Qualitative and Quantitative Dosage of the Anti M-Type Phospholipase A2 Receptor Autoantibody: One-Year Experience in Quebec’s Reference Center

open access: yes, 2021
Supplemental material, sj-pdf-1-cjk-10.1177_20543581211052729 for Qualitative and Quantitative Dosage of the Anti M-Type Phospholipase A2 Receptor Autoantibody: One-Year Experience in Quebec’s Reference Center by Simon Leclerc, Karim Benkirane, Annie ...
Simon Leclerc (1862623)   +8 more
core   +1 more source

Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysis

open access: yesBMC Nephrology, 2019
Background The diagnostic value of serum M-type phospholipase A2 receptor antibody (sPLA2R-ab) expression in patients with primary membranous nephropathy (PMN) has been established.
Yufeng Liang   +3 more
doaj   +1 more source

Advances in antigens associated with Idiopathic Membranous Nephropathy

open access: yesJournal of the Formosan Medical Association, 2021
Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. Idiopathic MN (IMN), one of the forms of MN, usually has an unknown etiology. IMN is described as an autoimmune disease, and its pathogenesis is quite complex.
Shan-Shan Li, Dong-E Tang, Yong Dai
doaj   +1 more source

Primary Membranous Nephropathy With Enhanced Staining of Exostosin 1/Exostosin 2 in the Glomeruli: A Report of 2 Cases

open access: yesKidney Medicine, 2021
Technological advances have allowed the discovery of 6 subtypes of membranous nephropathy based on target antigens: M-type phospholipase A2 receptor (PLA2R), thrombospondin type 1 domain-containing 7A (THSD7A), neural epidermal growth factor-like 1 ...
Takamasa Iwakura   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy